Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Fesia Grasp

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Early Phase 1 (2)

Trial Status

Unknown1
Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05509608Early Phase 1Active Not RecruitingPrimary

Evaluating a New Sensor That Measures the Health of the Retina in Normally-sighted Subjects

NCT06638775Not ApplicableUnknownPrimary

Functional Electrostimulation on the Upper Lip in Multiple Sclerosis

NCT06109025Early Phase 1CompletedPrimary

Improvement of Motor Imaginative Ability Through Functional Electrical Stimulation

Showing all 3 trials

Research Network

Common Treatments

  • Fesia Grasp2
  • Globus Elite2
  • Rm Electrode1
  • Erg Jet Electrode1
  • Virtual Rehab1

Active Sponsors

  • Universidad de Burgos2
  • RetMap, Inc1
  • Illinois College of Optometry1
  • University of Illinois at Chicago1

Top Investigators

Related Conditions

  • Therapy1
  • Therapy Directly Observed1
  • Directly Observed Therapy1

Activity Timeline